SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Feb. 23, 2026 |
Jan. 29, 2026 |
Jan. 15, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Feb. 05, 2026 |
|
| Subsequent Event [Line Items] | ||||||
| Proceeds from offerings | $ 2,160,656 | $ 3,713,139 | ||||
| Common Stock [Member] | ||||||
| Subsequent Event [Line Items] | ||||||
| Common shares issued for private placement, shares | 1,488,096 | |||||
| Subsequent Event [Member] | ||||||
| Subsequent Event [Line Items] | ||||||
| Secured Debt | $ 166,000 | |||||
| Debt Instrument, Interest Rate During Period | 1.00% | |||||
| Proceeds from offerings | $ 2,000,000.0 | |||||
| Cash fee percentage | 7.00% | |||||
| Management fee percentage | 1.00% | |||||
| Sale of stock, percentage | 7.00% | |||||
| Subsequent Event [Member] | Common Stock [Member] | ||||||
| Subsequent Event [Line Items] | ||||||
| Common shares issued for private placement, shares | 7,407,408 | |||||
| Price per share | $ 0.27 | |||||
| Subsequent Event [Member] | Pre-Funded Warrant [Member] | ||||||
| Subsequent Event [Line Items] | ||||||
| Warrant shares | 14,814,816 | |||||
| Warrant exercise price | $ 0.269 | |||||
| Subsequent Event [Member] | Share Purchase Agreement [Member] | ||||||
| Subsequent Event [Line Items] | ||||||
| Acquire percentage | 51.00% | |||||
| Consideration payable | $ 2,125,000 | |||||
| Share purchase agreement description | Company consummated the initial closing under the Share Purchase Agreement and acquired approximately 8% of Enquantum’s issued and outstanding share capital on a fully diluted basis. The initial closing included (i) the conversion of the previously issued $166,000 secured note into Enquantum ordinary shares and (ii) an additional cash investment representing the first milestone tranche. The Share Purchase Agreement provides for additional milestone-based tranche investments designed to increase the Company’s ownership interest to an aggregate of 51% on a fully diluted basis, subject to the satisfaction (or waiver) of specified operational and commercialization milestones and other customary conditions. In connection with the closing, the parties entered into an amendment to the Share Purchase Agreement granting the Company the right, at its discretion, to accelerate the funding of one or more future milestone tranches. The agreement also contemplates a final control top-up to increase the Company’s ownership from 48% to 51% on a fully diluted basis, for which the Company has agreed to issue shares of its common stock with an aggregate value of $125,000, based on the market price at the time of issuance. No such shares have been issued as of the date of these financial statements. | |||||
| Warrant exercise price | $ 0.3375 | |||||